New hope for slowing kidney decline in diabetics?
NCT ID NCT07187479
Summary
This study is testing if a treatment called Physiologic Insulin Resensitization (PIR) can help people with both advanced kidney disease and type 2 diabetes. It will compare PIR to standard care in 120 participants to see if it better protects kidney function and improves diabetes control. The goal is to see if making the body respond better to its own insulin can slow disease progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arizona Kidney Disease and Hypertension Center
RECRUITINGPhoenix, Arizona, 85027, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.